Olivier Litzka - Feb 9, 2023 Form 3 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role
Director
Signature
/s/ Adam Levy, Attorney-in-fact
Stock symbol
MLYS
Transactions as of
Feb 9, 2023
Transactions value $
$0
Form type
3
Date filed
2/9/2023, 06:54 PM
Next filing
May 1, 2023

No securities are beneficially owned.

Remarks:

EXHIBIT LIST: EX-24 Litzka Olivier POA